Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Am J Perinatol. 2017 Aug 14;35(1):78–83. doi: 10.1055/s-0037-1606119

Table 2.

Oxytocin dosing variables

Variable Dukea
N = 402
Pithagore6b
N = 6,907
p-Value
Maximal oxytocin infusion rate, mU/min 9.0 (5.0, 16.0) 7.5 (5.0, 12.5) <0.0001
Total duration of oxytocin infusion, h 11.6 (6.4, 20.4) 4.1 (2.2, 6.3) <0.0001
Oxytocin product, mU/min × h 173 (46, 880) 32.5 (11.8, 72.6) <0.0001
Oxytocin total dose (AUC), mU 3,525 (1,194, 9,822) 1,370 (540, 2,940) <0.0001

Abbreviation: AUC, area under the curve.

a

The Duke data are from 402 women.

b

The Pithagore6 data are as follows: 6,854 women with maximal infusion rate, 6,895 women with total duration of oxytocin infusion, 6,842 women with oxytocin product, and 6,907 with oxytocin total dose (AUC).

Note: Data presented are median (interquartile range).